Literature DB >> 32582794

Swapping of The N-Terminal Domain of Human Topoisomerase 1B with the Corresponding Plasmodium Falciparum Counterpart Strongly Impairs Enzyme Activity.

Jagadish Babu Dasari1, Bini Chhetri Soren1, Alessio Ottaviani1,2, Cinzia Tesauro1,3, Simona Marino1, Beatrice Messina1, Paola Fiorani1,2.   

Abstract

BACKGROUND: DNA topoisomerases 1B are a class of ubiquitous enzyme that solves the topological problems associated with biological processes such as replication, transcription and recombination. Numerous sequence alignment of topoisomerase 1B from different species shows that the lengths of different domains as well as their amino acids sequences are quite different. In the present study a hybrid enzyme, generated by swapping the N-terminal of Plasmodium falciparum into the corresponding domain of the human, has been characterized.
METHODS: The chimeric enzyme was generated using different sets of PCR. The in vitro characterization was carried out using different DNA substrate including radio-labelled oligonucleotides.
RESULTS: The chimeric enzyme displayed slower relaxation activity, cleavage and re-ligation kinetics strongly perturbed when compared to the human enzyme.
CONCLUSION: These results indicate that the N-terminal domain has a crucial role in modulating topoisomerase activity in different species.

Entities:  

Keywords:  N-terminal domain; Plasmodium falciparum topoisomerase 1B; Topoisomerase 1B

Year:  2020        PMID: 32582794      PMCID: PMC7275839     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  35 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein.

Authors:  James F Carey; Sharon J Schultz; Lisa Sisson; Thomas G Fazzio; James J Champoux
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-23       Impact factor: 11.205

Review 3.  Structure and mechanism of action of type IA DNA topoisomerases.

Authors:  D V Bugreev; G A Nevinsky
Journal:  Biochemistry (Mosc)       Date:  2009-12       Impact factor: 2.487

4.  A model for the mechanism of human topoisomerase I.

Authors:  L Stewart; M R Redinbo; X Qiu; W G Hol; J J Champoux
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

5.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

Authors:  M R Redinbo; L Stewart; P Kuhn; J J Champoux; W G Hol
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

6.  Reconstitution of human topoisomerase I by fragment complementation.

Authors:  L Stewart; G C Ireton; J J Champoux
Journal:  J Mol Biol       Date:  1997-06-13       Impact factor: 5.469

Review 7.  DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

Authors:  Carlos García-Estrada; Christopher Fernández Prada; Celia Fernández-Rubio; Francisco Rojo-Vázquez; Rafael Balaña-Fouce
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

8.  The gene encoding topoisomerase I from the human malaria parasite Plasmodium falciparum.

Authors:  K Tosh; B Kilbey
Journal:  Gene       Date:  1995-09-22       Impact factor: 3.688

9.  SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.

Authors:  E A Kauh; M A Bjornsti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  The domain organization of human topoisomerase I.

Authors:  L Stewart; G C Ireton; J J Champoux
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.